# Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants

> **NCT00131248** · PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 18 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Metaclopramide
- **DRUG:** Ranitidine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00131248
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131248, "Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00131248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*